LALPATHLAB

Dr. Lal Pathlabs Share Price

₹2,946.25 -76.25 (-2.52%)

22 Dec, 2024 21:48

SIP TrendupStart SIP in LALPATHLAB

Start SIP

Performance

  • Low
  • ₹2,935
  • High
  • ₹3,031
  • 52 Week Low
  • ₹1,944
  • 52 Week High
  • ₹3,654
  • Open Price₹3,020
  • Previous Close₹3,023
  • Volume88,530

Investment Returns

  • Over 1 Month -2.64%
  • Over 3 Month -10.5%
  • Over 6 Month + 10.2%
  • Over 1 Year + 13.72%
SIP Lightning

Smart Investing Starts Here Start SIP with Dr. Lal Pathlabs for Steady Growth!

Invest Now

Dr. Lal Pathlabs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 61.4
  • PEG Ratio
  • 1.8
  • Market Cap Cr
  • 24,627
  • P/B Ratio
  • 13.1
  • Average True Range
  • 72.69
  • EPS
  • 48.02
  • Dividend Yield
  • 1
  • MACD Signal
  • -21.56
  • RSI
  • 39.93
  • MFI
  • 57.56

Dr. Lal Pathlabs Financials

Dr. Lal Pathlabs Technicals

EMA & SMA

Current Price
₹2,946.25
-76.25 (-2.52%)
pointer
  • stock-down_img
  • Bullish Moving Average 2
  • stock-up_img
  • Bearish Moving Average 14
  • 20 Day
  • ₹3,036.84
  • 50 Day
  • ₹3,092.21
  • 100 Day
  • ₹3,084.86
  • 200 Day
  • ₹2,946.13

Resistance and Support

2970.68 Pivot Speed
  • R3 3,102.17
  • R2 3,066.48
  • R1 3,006.37
  • S1 2,910.57
  • S2 2,874.88
  • S3 2,814.77

What's your outlook on Dr. Lal Pathlabs?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Dr. Lal Path Labs Ltd. is one of India’s leading diagnostic and healthcare service providers, offering a wide range of tests and services through a network of over 200 labs and 3,000 patient service centers across the country.

Dr Lal Pathlabs has an operating revenue of Rs. 2,346.40 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 23% is great, ROE of 19% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 5% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 72 which is a FAIR score but needs to improve its earnings, a RS Rating of 52 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 34 indicates it belongs to a strong industry group of Medical-Services and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Dr. Lal Pathlabs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-23 Quarterly Results & Interim Dividend
2024-08-07 Quarterly Results & Interim Dividend
2024-05-10 Audited Results & Final Dividend
2024-02-01 Quarterly Results & Interim Dividend
2023-11-02 Quarterly Results
Date Purpose Remarks
2024-11-05 INTERIM Rs.6.00 per share(60%)Second Interim Dividend
2024-08-20 INTERIM Rs.6.00 per share(60%)Interim Dividend
2024-06-10 FINAL Rs.6.00 per share(60%)Final Dividend
2024-02-13 INTERIM Rs.12.00 per share(120%)Interim Dividend
2023-08-11 FINAL Rs.6.00 per share(60%)Final Dividend

Dr. Lal Pathlabs F&O

Dr. Lal Pathlabs Shareholding Pattern

53.92%
9.84%
2.54%
26.82%
0%
4.1%
2.78%

About Dr. Lal Pathlabs

  • NSE Symbol
  • LALPATHLAB
  • BSE Symbol
  • 539524
  • Managing Director
  • Dr. Om Prakash Manchanda
  • ISIN
  • INE600L01024

Similar Stocks to Dr. Lal Pathlabs

Dr. Lal Pathlabs FAQs

Dr. Lal Pathlabs share price is ₹2,946 As on 22 December, 2024 | 21:34

The Market Cap of Dr. Lal Pathlabs is ₹24627 Cr As on 22 December, 2024 | 21:34

The P/E ratio of Dr. Lal Pathlabs is 61.4 As on 22 December, 2024 | 21:34

The PB ratio of Dr. Lal Pathlabs is 13.1 As on 22 December, 2024 | 21:34

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23